08 - Epuration du phosphore en hémodialyse

Références

Covic A, Rastogi A. Hyperphosphatemia in patients with ESRD : assessing the current evidence linking outcomes with treatment adherence. BMC Nephrol. 2013 Jul 18 ;14:153. 23865421

Block GA, Rosenbaum DP, Yan A, Greasley PJ, Chertow GM, Wolf M. The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia. Nephrol Dial Transplant. 2019 Feb 1 ;34(2):339-346. 29617976

Negri AL, Ureña Torres PA. Iron-based phosphate binders : do they offer advantages over currently available phosphate binders ? Clin Kidney J. 2015 Apr ;8(2):161-7. 25815172

Fernández-Martín JL, Dusso A, Martínez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, Locatelli F, Górriz JL, Rutkowski B, Bos WJ, Tielemans C, Martin PY, Wüthrich RP, Pavlovic D, Benedik M, Rodríguez-Puyol D, Carrero JJ, Zoccali C, Cannata-Andía JB ; COSMOS group. Serum phosphate optimal timing and range associated with patients survival in haemodialysis : the COSMOS study. Nephrol Dial Transplant. 2019 Apr 1 ;34(4):673-681. 29741651

Ureña-Torres P, Prié D, Keddad K, Preston P, Wilde P, Wan H, Copley JB. Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate : results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial. BMC Nephrol. 2014 May 5 ;15:71. 24885942

Torres PU, Prié D, Beck L, De Brauwere D, Leroy C, Friedlander G. Klotho gene, phosphocalcic metabolism, and survival in dialysis. J Ren Nutr. 2009 Jan ;19(1):50-6. 19121771

Ureña-Torres P. Régulation de la phosphatémie : insuffisance rénale chronique et nouveaux facteurs l’influançant tels que le FGF23 (Fibroblast Growth Factor 23) et klotho. Série. Le Phosphore

Ureña Torres PA. Stratégies visant à réduire la phosphatémie dans la maladie rénale chronique [Strategies aiming to control hyperphosphatemia in chronic kidney disease]. Nephrol Ther. 2017 Apr ;13 Suppl 1:S95-S101. French. 28577750

Vervloet MG, Massy ZA, Brandenburg VM, Mazzaferro S, Cozzolino M, Ureña-Torres P, Bover J, Goldsmith D ; CKD-MBD Working Group of ERA-EDTA. Bone : a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. Lancet Diabetes Endocrinol. 2014 May ;2(5):427-36. 24795256

Torres PA, De Brauwere DP. Three feedback loops precisely regulating serum phosphate concentration. Kidney Int. 2011 Sep ;80(5):443-5. 21841832